Prostate cancer is no longer a death sentence; there is hope. That simply was not true five years ago. And five years from now, we’ll have grandfathers, fathers, uncles and brothers alive who never would have been if it hadn’t been for a common commitment to put prostate cancer out of business through research.
There is a moment up ahead where men will no longer be treated unnecessarily, where every man and family has the right information about prostate cancer.
With resolve and a total commitment of putting money in the hands of the very best doctors and scientists, prostate cancer will lead the way as the first major cancer to simply cease to be a cause of death and suffering.
At the same time, PCF funds key clinical trials as part of its efforts to shorten the time between drug development and FDA approval. In the past four years, PCF-funded science has seeded, in some cases invented, developed, and accelerated to patients six new, life-extending, FDA approved drugs for advanced prostate cancer.
We are incredibly proud of the work of the Prostate Cancer Foundation, and together we are all part of a community that has helped reduce United States prostate cancer deaths by 30%.
Learn more about the 2013 Young Investigators by visiting: pcf.org/younginvestigators
Learn more about PCF’s research accomplishments by visiting: pcf.org/accomplishments
The Prostate Cancer Foundation spends 83% of the funds it receives to empower the world’s top scientific minds by cutting red tape and encouraging collaboration to speed breakthroughs by funding ground-breaking research and helping raise awareness for the disease.